Active Surveillance for Low Risk Papillary Thyroid Cancer: Is immediate surgery always necessary?
R. Michael Tuttle, MD, Endocrinologist, Memorial Sloan-Kettering Cancer Center, New York, New York, Professor, Cornell School of Medicine
Upon completion of this session, participants will improve their competence and performance by being able to: Describe the concept of active e surveillance as an alternative to immediate treatment in thyroid cancer. Describe a practical approach to proper patient selection for active surveillance. Describe the growth kinetics of low risk papillary thyroid cancer.
Speaker Disclosures: Dr. Tuttle has no relevant financial relationships or affiliations with commercial interests to disclose.
For further information contact:
271-6651 ext. 54374